NARCAN NALOXONE HCL- narcan naloxone hcl spray 
HF Acquisition Co LLC, DBA HealthFirst

----------

ACTIVE INGREDIENT (IN EACH SPRAY)

Naloxone Hydrochloride 4 mg

Emergency treatment of opioid overdose

USES

When using this product some people may experience symptoms when they wake up, such as, shaking, sweating, nausea, or feeling angry. This is to be expected.

DIRECTIONS

Directions

Directions

For opioid emergencies, call 911. For questions on NARCAN, call 1-844-4NARCAN (1-844-462-7226) or go to WWW.NARCAN.COM.

©2023 Emergent Devices Inc. EMERGENT® and NARCAN® are registered trademarks of Emergent BioSolutions Inc, or its subsidiaries.

Other Information


store at room temperature or refrigerated, between 2°C to 25°C (36°F to 77°F)

do not freeze

avoid excessive heat above 40°C (104°F)

protect from light

the product is packaged in individually-sealed blisters.

Do not use if the blister is open or torn, or if the device appears damaged.

benzalkonium chloride, edetate disodium, hydrochloric acid, sodium chloride, water

Call 1-844-4NARCAN (1-844-462-7226) or go to WWW.NARCAN.COM

keep out of reach of children

PRINCIPAL DISPLAY PANEL- CARTON LABEL

CARTON LABEL

PRINCIPAL DISPLAY PANEL_ NDC 51662-1642-1

pack

RFID Label

PRINCIPAL DISPLAY PANEL- NDC 51662-1642-2

pack

RFID Label

NARCAN NALOXONE HCL 
narcan naloxone hcl spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51662-1642(NDC:69547-627)
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NALOXONE HYDROCHLORIDE (UNII: F850569PQR) (NALOXONE - UNII:36B82AMQ7N) NALOXONE HYDROCHLORIDE4 mg  in 0.1 mL
Inactive Ingredients
Ingredient NameStrength
HYDROCHLORIC ACID (UNII: QTT17582CB)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51662-1642-22 in 1 CARTON08/28/2023
1NDC:51662-1642-10.1 mL in 1 VIAL, SINGLE-DOSE; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA20841108/28/2023
Labeler - HF Acquisition Co LLC, DBA HealthFirst (045657305)
Registrant - HF Acquisition Co LLC, DBA HealthFirst (045657305)
Establishment
NameAddressID/FEIBusiness Operations
HF Acquisition Co LLC, DBA HealthFirst045657305relabel(51662-1642)

Revised: 2/2024
Document Id: 11d770b8-b769-ba3d-e063-6394a90a61a6
Set id: 11d770b8-b768-ba3d-e063-6394a90a61a6
Version: 1
Effective Time: 20240220
 
HF Acquisition Co LLC, DBA HealthFirst